Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Haematologica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15339679
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classical Hodgkin lymphoma arising in the rectum.

  2005cited by this paper
• Differential Eµ enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B‐cell populations, B‐cell non‐Hodgkin lymphomas, and Hodgkin lymphomas

  2004cited by this paper
• Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

  2003cited by this paper
• Leucocyte‐specific protein (LSP1) in malignant lymphoma and Hodgkin's disease

  2003cited by this paper
• Characterization of Variant Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Immunohistologic and Clinical Correlation

  2003influential reference
• T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity.

  2002cited by this paper
• Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma.

  2002cited by this paper
• T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Heterogeneous Entity With Derivation From Germinal Center B Cells

  2002cited by this paper
• Histiocyte‐rich, T‐cell‐rich B‐cell lymphoma: a distinct diffuse large B‐cell lymphoma subtype showing characteristic morphologic and immunophenotypic features

  2002cited by this paper
• Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease.

  2002cited by this paper
• T‐cell/histiocyte‐rich large B‐cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma

  2002cited by this paper
• T-cell Rich B-cell Lymphoma: Clinical Distinctiveness and Response to Treatment in 45 Patients

  2002cited by this paper
• Modulation of Mac-1 (CD11b/CD18)-Mediated Adhesion by the Leukocyte-Specific Protein 1 Is Key to Its Role in Neutrophil Polarization and Chemotaxis1

  2002cited by this paper
• Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma.

  2002cited by this paper
• Aberrant expression and localization of the cytoskeleton-binding pp52 (LSP1) protein in hairy cell leukemia.

  2001cited by this paper
• Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.

  2001cited by this paper
• TARC, a CC Chemokine, Is Frequently Expressed in Classic Hodgkin's Lymphoma But Not in NLP Hodgkin's Lymphoma, T-Cell-Rich B-Cell Lymphoma, and Most Cases of Anaplastic Large Cell Lymphoma

  2001cited by this paper
• Hair-forming activity of human lymphocyte specific protein 1 requires cooperation between its caldesmon-like domains and the villin headpiece-like domains.

  2001cited by this paper
• The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

  2001influential reference
• Double immunofluorescence labelling of routinely processed paraffin sections

  2000cited by this paper
• European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.

  2000cited by this paper
• LSP1 modulates the locomotion of monocyte-differentiated U937 cells.

  2000cited by this paper
• LSP1 modulates leukocyte populations in resting and inflamed peritoneum.

  2000cited by this paper
• Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells.

  1999cited by this paper
• The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages.

  1999cited by this paper
• The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques.

  1998cited by this paper
• Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).

  1998cited by this paper
• Transcriptional regulation during B cell development.

  1998cited by this paper
• Clonality in nodular lymphocyte-predominant Hodgkin's disease.

  1997cited by this paper
• Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells.

  1997cited by this paper
• Antigen retrieval techniques in immunohistochemistry: comparison of different methods

  1997cited by this paper
• CD45 immunostaining in T-cell-rich B-cell lymphoma and lymphocyte predominance Hodgkin's disease.

  1997cited by this paper
• T‐cell rich B‐cell non‐Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease

  1996cited by this paper
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

  1994cited by this paper
• Histiocyte‐Rich B‐Cell Lymphoma: A Distinct Clinicopathologic Entity Possibly Related to Lymphocyte Predominant Hodgkin's Disease, Paragranuloma Subtype

  1992cited by this paper
• T‐Cell-Rich B‐Cell Lymphomas: A Clinicopathologic Study of 19 Cases

  1992cited by this paper
• Large B‐cell lymphoma rich in T‐cells and simulating Hodgkin's disease

  1991cited by this paper
• Histological and immunohistological analysis of human lymphomas.

  1989cited by this paper
• T‐Cell-Rich B‐Cell Lymphoma

  1988cited by this paper
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

  1984cited by this paper

• Combined complement and coagulation activation in ST-elevation myocardial infarction: associations with myocardial injury and dysfunction

  2025cites this paper
• Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds

  2025cites this paper
• Pediatric T-Cell/Histiocyte-Rich Large B-Cell Lymphoma (THRLBC) in an 8-Year-Old Male Child: A Case Report

  2025cites this paper
• Leukocyte Specific Protein 1 Deficiency Impairs Anti‐Melanoma Immunity by Disrupting DC and CD8 + T Cell Function in Mice

  2025cites this paper
• Consolidation therapy with autologous stem cell transplantation after remission of induction chemotherapy prolongs the survival of patients with peripheral T-cell lymphoma

  2024cites this paper
• Roles of IL-11 in the regulation of bone metabolism

  2024cites this paper
• Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors: a review

  2024cites this paper
• N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment

  2024cites this paper
• Advances and challenges in anti-cancer vaccines for multiple myeloma

  2024cites this paper
• Comprehensive summary: the role of PBX1 in development and cancers

  2024cites this paper
• Atypical Sweet syndrome: skin sinus tracts in an acutely febrile patient after lymphoma treatment: a case report

  2023cites this paper
• Editorial: Case reports in hematological malignancies: 2022

  2023cites this paper
• An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies

  2023cites this paper
• Autophagy and the Bone Marrow Microenvironment: A Review of Protective Factors in the Development and Maintenance of Multiple Myeloma

  2022cites this paper
• Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical management

  2022cites this paper
• Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia

  2022cites this paper
• The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity

  2021cites this paper
• Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target

  2021influential citation
• Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies

  2021cites this paper
• Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma.

  2019cites this paper
• A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes

  2018cites this paper
• The Pathobiology and Treatment of Hodgkin Lymphoma. Where do We go from Gianni Bonadonna's Lesson?

  2017cites this paper
• The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status

  2017cites this paper
• Lymphocyte‐specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation

  2016cites this paper
• T-cell/histiocyte-rich large B-cell lymphoma in pediatric patients: an under-recognized entity?

  2015cites this paper
• Study of the diagnostic utility of fascin and PU.1 in Hodgkin’s lymphoma, diffuse large B-cell lymphoma, and anaplastic large cell lymphoma

  2014cites this paper
• Fatal Necrotizing Angiotropic Epstein–Barr Virus-negative Large B-cell Lymphoma

  2014cites this paper
• Pathobiology of Hodgkin Lymphoma

  2014cites this paper
• Cobbold Memory-like Immunity in Leukemia Associated Phosphopeptides Are the Targets of − MHC Class

  2013cites this paper
• MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia

  2013cites this paper
• MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia

  2013cites this paper
• Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?

  2013cites this paper
• "Old" is "new" in diagnostic pathology.

  2013cites this paper
• Bone Marrow in Hodgkin Lymphoma and Mimickers

  2012cites this paper
• T‐cell‐rich B‐cell lymphoma (TCRBCL): Limitations in fine‐needle aspiration cytodiagnosis

  2012cites this paper
• Nodular Lymphocyte-Predominant Type of Hodgkin's Lymphoma

  2011cites this paper
• T-cell/histiocyte-rich large B-cell lymphoma

  2010cites this paper
• Pathobiology of Hodgkin Lymphoma

  2010cites this paper
• Hodgkin's lymphoma: Diagnostic difficulties in fine‐needle aspiration cytology

  2009influential citation
• Defining the molecular target of an antibody derived from nuclear extract of Jurkat cells using protein arrays.

  2009cites this paper
• Histopathology of Hodgkin’s Lymphoma

  2009cites this paper
• PD-1, a Follicular T-cell Marker Useful for Recognizing Nodular Lymphocyte-predominant Hodgkin Lymphoma

  2008cites this paper
• Selective loss of B‐cell phenotype in lymphocyte predominant Hodgkin lymphoma

  2007cites this paper
• Diagnosis of Hodgkin's disease: an update on histopathological and immunophenotypical features.

  2007cites this paper
• Discovering biomarkers from gene expression data for predicting cancer subgroups using neural networks and relational fuzzy clustering

  2007cites this paper
• Transmembrane adaptor molecules: a new category of lymphoid-cell markers.

  2006cites this paper
• IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin Lymphoma

  2006cites this paper
• Hodgkin’s lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments

  2006cites this paper
• Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.

  2005cites this paper
• Nodal aggressive non-Hodgkin’s lymphoma in the adult: a review article

  2005cites this paper